Lego (Hive Bee) 04-30-04 18:12 No 504079 |
Novel Agonists of 5HT2C Receptors (Rated as: excellent) |
|||||||
Novel Agonists of 5HT2C Receptors Synthesis and Biological Evaluation of Substituted 2-(Indol-1-yl)-1-methylethylamines and 2-(Indeno[1,2-b]pyrrol-1-yl)-1-methyleth Improved Therapeutics for Obsessive Compulsive Disorder Michael Bös, Francois Jenck, James R. Martin, Jean-Luc Moreau, Andrew J. Sleight, Jürgen Wichmann, and Ulrich Widmer J. Med. Chem. 1997, 40, 2762-2769 DOI:10.1021/jm970030l Abstract The syntheses of a series of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methyleth Scheme 1 (a) Propylene oxide, NaH, THF; (b) MsCl, NEt3, CH2Cl2; (c) NaN3, DMF; (d) PtO2, H2, EtOH. Scheme 3 (a) 3-Buten-2-ol, p-TsA, 2,2-dimethoxypropane; (b) ozone, CH2Cl2-MeOH; (c) TFA, CH2Cl2; (d) 1-amino-2-propanol, p-TsA, toluene; (e) MsCl, NEt3, CH2Cl2; (f) NaN3, DMF; (g) PtO2, H2, EtOH. The tendency is to push it as far as you can |
||||||||
Rhodium (Chief Bee) 04-30-04 19:36 No 504095 |
5- and 6-Fluorinated Analogs of AMT & DET (Rated as: good read) |
|||||||
This is reference #6, which I find interesting: Synthesis and Pharmacological Activity of Fluorinated Tryptamine Derivatives Asher Kalir, Stephen Szara, J. Med. Chem. 6, 716-719 (1963) Abstract The synthesis of several fluorinated tryptamine derivatives in which the fluorine atom occupies the 5- or 6-position is reported. The 5-fluoro and unsubstituted tryptamines are more active than the 6-substituted derivatives in inducing spontaneous locomotion when administered to reserpinized white mice. Both 6-fluoro-N,N-diethyltryptamine and N,N-diethyltryptamine exerted peripheral activity when tested in humans, hut only the fluorine-free compound seemed to bear hallucinogenic properties. These results may be explained by change in the metabolic pathway of the tryptamines with substituted 6-position in the indole nucleus.
|
||||||||
Lego (Hive Bee) 05-01-04 11:37 No 504212 |
Indolines&benzodiazepinoindoles as 5-HT2C agonists (Rated as: good read) |
|||||||
Indoline derivatives as 5-HT2C receptor agonists J. M. Bentley, D. R. Adams, D. Bebbington, K. R. Benwell, M. J. Bickerdike, J. E. P. Davidson, C. E. Dawson, C. T. Dourish, M. A. J. Duncton, S. Gaur, A. R. George, P. R. Giles, R. J. Hamlyn, G. A. Kennett, A. R. Knight, C. S. Malcolm, H. L. Mansell, A. Misra, N. J. T. Monck, R. M. Pratt, K. Quirk, J. R. A. Roffey, S. P. Vickers and I. A. Cliffe Bioorg. Med. Chem., 2004, 14, 2367-2370 DOI:10.1016/j.bmcl.2003.05.001 Abstract A series of 1-(1-indolinyl)-2-propylamines was synthesised and evaluated as 5-HT2C receptor agonists for the treatment of obesity. The general methods of synthesis of the precursor indoles are described. The functional efficacy and radioligand binding data for all of the compounds at 5-HT2 receptor subtypes are reported. A number of compounds were found to reduce food intake in rats after oral administration. ____ ___ __ _ Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor Annmarie L. Sabb, Robert L. Vogel, Gregory S. Welmaker, Joan E. Sabalski, Joseph Coupet, John Dunlop, Sharon Rosenzweig-Lipsonb and Boyd Harrison Bioorg. Med. Chem., 2004, DOI:10.1016/j.bmcl.2004.02.100 Abstract Evaluation of selected compounds from our Corporate Compound Library in a human 5-HT2C receptor binding assay led to the discovery of WAY-629, a cyclohexyl[b][1,4]benzodiazepinoindole (Ki 56 nM, Emax 90%), which is selective for the 5-HT2C receptor versus other serotonin receptor subtypes, and dopamine, histamine, adrenergic, and muscarinic receptors. In addition, WAY-629 was active in vivo in a rat model of feeding behavior. An SAR study based on WAY-629 led to compound 11 (Ki 13 nM, Emax102%). The tendency is to push it as far as you can |
||||||||
Lego (Hive Bee) 07-09-04 13:13 No 518432 |
More indole based 5-HT2C agonists (Rated as: good read) |
|||||||
2,3,4,5-Tetrahydro- and 2,3,4,5,11,11a-Hexahydro-1H-[1,4]diazepi Michael D. Ennis, Robert L. Hoffman, Nabil B. Ghazal, Rebecca M. Olson, Christopher S. Knauer, Chris L. Chio, Deborah K. Hyslop, Jeffery E. Campbell, Lawrence W. Fitzgerald, Nanette F. Nichols, Kjell A. Svensson, Robert B. McCall, Christopher L. Haber, Michelle L. Kageyc and Dac M. Dinh Bioorg. Med. Chem. Lett., 2003, 13(14), 2369-2372 DOI:10.1016/S0960-894X(03)00403-7 Abstract: The design and synthesis of the novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7 The tendency is to push it as far as you can |
||||||||